Hungary to use Chinese vaccine as strategic advantage

Hungary’s planned Covid vaccine production plant will also be equipped to manufacture Chinese Covid vaccines, according to media reports. This was announced by Hungary’s Foreign Minister Péter Szijjártó after a meeting with his Chinese counterpart Wang Yi on Monday, Reuters reported citing Hungary’s state news agency MIT. According to the report, the agreement represents a „great strategic advantage“ for Hungary, Szijjártó said. Hungary would become the first EU state to produce Chinese vaccines. It remained unclear when production of the Chinese vaccine could begin in Hungary. Sinopharm’s product does not yet have European Medicines Agency (EMA) approval for the EU. Hungary decided to use the vaccine with emergency approval.